Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion.
about
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion InjuryImmunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapySphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury.Extracellular Vesicles in Renal Diseases: More than Novel Biomarkers?A novel cytoprotective peptide protects mesenchymal stem cells against mitochondrial dysfunction and apoptosis induced by starvation via Nrf2/Sirt3/FoxO3a pathway.Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods.The effect of two novel amino acid-coated magnetic nanoparticles on survival in vascular endothelial cells, bone marrow stromal cells, and macrophagesActivation of the calcium-sensing receptor before renal ischemia/reperfusion exacerbates kidney injury.Incidence and outcomes of acute kidney injury after cardiac surgery using either criteria of the RIFLE classificationNuclear Magnetic Resonance Metabolomic Profiling of Mouse Kidney, Urine and Serum Following Renal Ischemia/Reperfusion InjuryMesenchymal stem cell therapy promotes the improvement and recovery of renal function in a preclinical model.Study of the Effect of Route of Administration of Mesenchymal Stem Cells on Cisplatin-Induced Acute Kidney Injury in Sprague Dawley RatsRationale for the potential use of mesenchymal stromal cells in liver transplantation.Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment.Stem cell therapy for ischemic heart diseases.Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells.Implications of the calcium-sensing receptor in ischemia/reperfusion.Mesenchymal Stromal Cells Accelerate Epithelial Tight Junction Assembly via the AMP-Activated Protein Kinase Pathway, Independently of Liver Kinase B1.Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in ratsLong Term Study of Protective Mechanisms of Human Adipose Derived Mesenchymal Stem Cells on Cisplatin Induced Kidney injury in Sprague-Dawley RatsNeuroprotective Effects of Bioactive Compounds and MAPK Pathway Modulation in "Ischemia"-Stressed PC12 Pheochromocytoma Cells.Dual Preconditioning: A Novel Strategy to Withstand Mesenchymal Stem Cells against Harsh Microenvironments
P2860
Q26799905-7DB1F948-7BDA-4D65-A08D-0069F514043CQ29994669-ED81FD2C-3814-4AEF-B9CA-F75315CCA32EQ30278837-C1BD1A3C-19D5-4B43-B3CF-8A77E402C780Q30278885-5814DFE5-9ED2-4212-A250-31982657B11EQ32182028-FC726F55-4798-45C9-9713-444C5B282703Q33793437-E9291E84-0052-4F72-BA54-6668A0678FEAQ34256625-6DA04C2A-A422-487A-A09E-F861F0B28200Q35137812-A3E781B5-E729-47D4-818E-8C22E758F0A1Q35646583-EE5587E4-9D5E-4E1B-A59A-C1FB697B1B01Q36140947-75CC3EE7-68AE-433C-8556-32F0C67DA4E9Q37011969-DC811D11-8474-4EF8-8A76-FDDABC8C78E8Q37126556-2857C66A-E702-4CA4-948D-34734275F93CQ38282065-B4C3E0B9-303D-4097-894A-BE9BFEF05C02Q38541350-5E1103EE-BECF-4A85-A2C6-A48C767B8EB8Q38761212-699AD79D-E205-4002-8992-8C8FFE4EC339Q39279238-59CD6FEE-2BBF-489A-909D-B7071A63A615Q39361694-308BADF5-D0EF-4826-98B2-65C671CFDD3EQ41110512-3388DC6E-516A-4791-8F60-B1019363AA00Q41447058-334DA369-ECF3-4B56-962E-697C19FF4F49Q42039222-D72A3617-D01A-4FAB-AE30-DA00E32DE952Q50117414-C489B929-840C-439B-95A9-EE700A918246Q57136159-26329EC3-2EAD-48BB-B5B0-03D10D84053D
P2860
Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion.
@en
type
label
Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion.
@en
prefLabel
Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion.
@en
P2093
P2860
P356
P1476
Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion
@en
P2093
Alexandra Briquet
Catherine Bonvoisin
Chantal Lechanteur
François Jouret
Jean-Marie Krzesinski
Laurent Weekers
Pauline Erpicum
Yves Beguin
P2860
P304
P356
10.1093/NDT/GFT538
P407
P577
2014-02-09T00:00:00Z